Final SCCS Opinion on CBD

Final SCCS Opinion on CBD

Summary: On 24 April 2026, the SCCS concluded that pure CBD is safe for use in dermal and oral cosmetic products at concentrations up to 0.19%, with THC impurities permitted up to 0.00025%. Products that may result in inhalation exposure were not assessed. On 24 April...
Final SCCS Opinion on CBD

Cannabidiol (CBD) – SCCS Draft Opinion

It was concluded that CBD is safe for use in dermal cosmetics and oral cosmetics in concentration no more than 0.19%. THC impurities are safe for use at concentrations no more than 0.00025% in both dermal and oral cosmetics. Inhalation risk exposure was not assessed...
CBD – Weighty evidence for CBD reprotoxicity classification

CBD – SCCS Mandate

Following a call of data by the EU Commission on the use of CBD in cosmetics (available here), on 22 January 2025 the Scientific Committee on Consumer Safety (SCCS) was mandated to review the safety of cannabidiol (CBD) in cosmetic products. The mandate is available...